Ultrapar Participacoes S.A.:企業の戦略・SWOT・財務分析

◆英語タイトル:Ultrapar Participacoes S.A. - Strategy, SWOT and Corporate Finance Report
◆商品コード:SWOT20MY4811
◆発行会社(調査会社):MarketLine
◆発行日:2020年2月
◆ページ数:40
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ブラジル
◆産業分野:Chemicals
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Ultrapar Participacoes S.A. – Strategy, SWOT and Corporate Finance Report
Summary

Ultrapar Participacoes S.A. – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Ultrapar Participacoes S.A (Ultrapar or ‘the company’) operates specialized distribution and retail operations. Its major operations include the distribution of liquefied petroleum gas (LPG), fuel, production and marketing of chemicals such as ethylene oxide and its derivatives, and the distribution of pharmaceutical products. The company also provides liquid bulk storage facilities. Ultrapar serves retail, industrial, and commercial customers. It operates drug distribution center in Belem, Para; storage facilities at Itaqui, Suape, Aratu, Rio de Janeiro, Santos, Paranagua, and Paulinia; and production facilities in Brazil, the US, Uruguay, Mexico and Venezuela.The company has operations across Brazil, Mexico, Venezuela, the US, Canada, Latin America, the Far East, and Europe. The company is headquartered in Sao Paulo, Brazil.

Scope

- Detailed information on Ultrapar Participacoes S.A. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Ultrapar Participacoes S.A. in the form of a SWOT analysis
- An in-depth view of the business model of Ultrapar Participacoes S.A. including a breakdown and examination of key business segments
- Intelligence on Ultrapar Participacoes S.A.’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Ultrapar Participacoes S.A., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Ultrapar Participacoes S.A. and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Ultrapar Participacoes S.A. as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Ultrapar Participacoes S.A.’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot
Table of Contents
Ultrapar Participacoes S.A.: Company Overview
Ultrapar Participacoes S.A.: Overview and Key Facts
Ultrapar Participacoes S.A.: Overview
Ultrapar Participacoes S.A.: Key Facts
Ultrapar Participacoes S.A.: Key Employees
Ultrapar Participacoes S.A.: Key Employee Biographies
Ultrapar Participacoes S.A.: Major Products and Services
Ultrapar Participacoes S.A.: Company History
Ultrapar Participacoes S.A.: Management Statement
Ultrapar Participacoes S.A.: Locations and Subsidiaries
Ultrapar Participacoes S.A.: Key Competitors
Ultrapar Participacoes S.A.: Company Analysis
Ultrapar Participacoes S.A.: Business Description
Ultrapar Participacoes S.A.: SWOT Analysis
Ultrapar Participacoes S.A.: SWOT Overview
Ultrapar Participacoes S.A.: Strengths
Ultrapar Participacoes S.A.: Weaknesses
Ultrapar Participacoes S.A.: Opportunities
Ultrapar Participacoes S.A.: Threats
Ultrapar Participacoes S.A.: Corporate Financial Deals Activity
Ultrapar Participacoes S.A.: Financial Deals Overview
Ultrapar Participacoes S.A.: Top Deals 2016 – 2020YTD*
Ultrapar Participacoes S.A.: Capital Raising
Ultrapar Participacoes S.A.: Recent Developments
Ultrapar Participacoes S.A.: News and Events Summary
Ultrapar Participacoes S.A.: Business Expansion
Ultrapar Participacoes S.A.: Contracts
Ultrapar Participacoes S.A.: Financial Performance
Ultrapar Participacoes S.A.: Regulatory and Legal Events
Ultrapar Participacoes S.A.: Strategy and Operations
Appendix
Contact Us
Methodology
About MarketLine

List of Tables
Table 1: Ultrapar Participacoes S.A.: Key Facts
Table 2: Ultrapar Participacoes S.A.: Key Employees
Table 3: Ultrapar Participacoes S.A.: Company History
Table 4: Ultrapar Participacoes S.A.: Locations and Subsidiaries
Table 5: Ultrapar Participacoes S.A.: Key Competitors
Table 6: Ultrapar Participacoes S.A.: Deal Activity by Deal Type - Volume (2016 - YTD*2020)
Table 7: Ultrapar Participacoes S.A.: Top Deals 2016 - 2020YTD*
Table 8: Ultrapar Participacoes S.A.: Capital Raising Volume and Value Trend (2016 - YTD*2020)
Table 9: Ultrapar Participacoes S.A.: Capital Raising by Deal Type (2016 - YTD*2020)
Table 10: Ultrapar Participacoes S.A.: News and Events Summary
Table 11: Ultrapar Participacoes S.A.: Business Expansion
Table 12: Ultrapar Participacoes S.A.: Contracts
Table 13: Ultrapar Participacoes S.A.: Financial Performance
Table 14: Ultrapar Participacoes S.A.: Regulatory and Legal Events
Table 15: Ultrapar Participacoes S.A.: Strategy and Operations

★海外企業調査レポート[Ultrapar Participacoes S.A.:企業の戦略・SWOT・財務分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Sage Therapeutics Inc (SAGE):製薬・医療:M&Aディール及び事業提携情報
    Summary Sage Therapeutics Inc (Sage) is a clinical-stage biopharmaceutical company that discovers and develops therapeutics and medicines for central nervous system (CNS) disorders. It develops drugs based on selective allosteric modulation of CNS synaptic and extrasynaptic receptors. The company ha …
  • Endo International Plc (ENDP):企業の財務・戦略的SWOT分析
    Endo International Plc (ENDP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Lite-On Technology Corporation:企業の戦略・SWOT・財務情報
    Lite-On Technology Corporation - Strategy, SWOT and Corporate Finance Report Summary Lite-On Technology Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Soitec SA (SOI):電力:M&Aディール及び事業提携情報
    Summary Soitec S.A. (Soitec) is a designer and manufacturer of semiconductor materials. The company offers solutions for miniaturizing chips. Its products are used to manufacture chips which are used in smartphones, tablets, computers, IT servers and data centers, electronic components in cars, conn …
  • Cenveo, Inc.:企業の戦略的SWOT分析
    Cenveo, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Endress+Hauser AG:企業の戦略的SWOT分析
    Endress+Hauser AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • Merus NV (MRUS):企業の財務・戦略的SWOT分析
    Summary Merus NV (Merus) is a clinical-stage immuno-oncology company that discovers and develops human bispecific antibody therapeutics for the treatment of cancer. The company’s pipeline antibody candidates are intended for the treatment of breast cancer, ovarian cancer, colorectal cancer, acute my …
  • ThreeD Capital:企業のM&A・事業提携・投資動向
    ThreeD Capital - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's ThreeD Capital Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestmen …
  • The Tata Power Co Ltd (TATAPOWER):企業の財務・戦略的SWOT分析
    The Tata Power Co Ltd (TATAPOWER) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Hanwha Chemical Corp (009830):企業の財務・戦略的SWOT分析
    Summary Hanwha Chemical Corp (Hanwha), a subsidiary of Hanwha Corp is a chemical company that manufactures, develops, and distributes basic industrial chemicals, general purpose plastic products, and other chemical products. The company's chemical products include inorganic compounds, PVC, polymers, …
  • Hyundai Marine & Fire Insurance Co Ltd:企業の戦略・SWOT・財務情報
    Hyundai Marine & Fire Insurance Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Hyundai Marine & Fire Insurance Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT ana …
  • Vanda Pharmaceuticals Inc (VNDA):製薬・医療:M&Aディール及び事業提携情報
    Summary Vanda Pharmaceuticals Inc (Vanda Pharmaceuticals) is a specialty pharmaceutical company that develops and commercializesnovel therapies for the treatment of central nervous system disorders. The company’s products include Hetlioz, a melatonin receptor agonist for the treatment of non-24-hour …
  • DNO ASA (DNO):企業の財務・戦略的SWOT分析
    Summary DNO ASA (DNO) is an oil and gas company that provides mineral properties exploration and development services. The company's services include selective and targeted drilling, fractured carbonate plays that are characteristic of the MENA region. It also provides operations in petroleum, shipp …
  • Breakthru Beverage Group, LLC:企業の戦略・SWOT・財務情報
    Breakthru Beverage Group, LLC - Strategy, SWOT and Corporate Finance Report Summary Breakthru Beverage Group, LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Double Bond Pharmaceutical International AB (DBPB):製薬・医療:M&Aディール及び事業提携情報
    Summary Double Bond Pharmaceutical International AB (DBP) is a pharmaceutical company that design, develop and commercialize therapies for cancer and autoimmune diseases. The company’s product pipeline includes SI-053 (Temodex), a novel therapy to treat malignant brain tumors; SA-033, SA-042, and SA …
  • CryoLife Inc (CRY):医療機器:M&Aディール及び事業提携情報
    Summary CryoLife Inc (CryoLife) is a provider of biosurgical devices and implantable living tissues for cardiac and vascular surgical procedures. The company’s portfolio enlists preserved human cardiac allografts, vascular allografts, surgical adhesives and sealants, heart valves, carbon dioxide dif …
  • Premier Foods plc (PFD):企業の財務・戦略的SWOT分析
    Premier Foods plc (PFD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Candover Investments plc (CDI):企業の財務・戦略的SWOT分析
    Candover Investments plc (CDI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Royal DSM NV (DSM)-製薬・医療分野:企業M&A・提携分析
    Summary Royal DSM NV (DSM) is a life sciences and materials sciences company, which focuses on health, nutrition and materials sectors. The company offers a wide range of products such as anti-invectives, polyesters, vitamins and other ingredients, performance materials to diverse end markets. It pr …
  • VOCO GmbH:企業の戦略的SWOT分析
    VOCO GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Th …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆